ACW $11. 1m Capital Raising

Today Actinogen Medical announced a $11m capital raising to accelerate its Alzheimer's Phase 2b/3 trial to full enrolment. An institutional placement of $7.0m was 2 x oversubscribed, with CEO Steven Gourlay investing a further $1m in the placement alongside commitments from other directors. Shareholders to participate via a $3m SPP on the same terms.